These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7648788)

  • 1. The role of plasma, erythrocyte and platelet myo-inositol levels in the development of diabetic microangiopathy.
    Hacibekiroğlu M; Akçay T
    Diabetes Res; 1994; 25(4):173-9. PubMed ID: 7648788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. myo-Inositol and sorbitol in erythrocytes from diabetic patients before and after sorbinil treatment.
    Popp-Snijders C; Lomecky-Janousek MZ; Schouten JA; van der Veen EA
    Diabetologia; 1984 Nov; 27(5):514-6. PubMed ID: 6439588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythrocyte, plasma total, ultrafiltrable and platelet magnesium in type 2 (non-insulin dependent) diabetes mellitus.
    Crook M; Couchman S; Tutt P; Amiel S; Swaminathan R
    Diabetes Res; 1994; 27(2):73-9. PubMed ID: 7671556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relation between plasma endothelin-1 levels and metabolic control, risk factors, treatment modalities, and diabetic microangiopathy in patients with Type 2 diabetes mellitus.
    Ak G; Buyukberber S; Sevinc A; Turk HM; Ates M; Sari R; Savli H; Cigli A
    J Diabetes Complications; 2001; 15(3):150-7. PubMed ID: 11358684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rheological changes in diabetic microangiopathy.
    Negrean V; Suciu I; Sâmpelean D; Cozma A
    Rom J Intern Med; 2004; 42(2):407-13. PubMed ID: 15529630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased platelet malondialdehyde, but normal platelet sensitivity to adenosine-5-diphosphate and prostacyclin in well-controlled type 1 diabetics without vascular complications.
    Gisinger C; Schernthaner G
    Diabetes Res; 1986 Oct; 3(8):401-5. PubMed ID: 3545622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet hyper- and hypoaggregability in different microangiopathic complications of diabetes mellitus.
    Szénási P; Tóth L; Romics L; Kammerer L
    Acta Diabetol Lat; 1988; 25(1):7-12. PubMed ID: 3407379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between glycemic control and platelet activity in type 2 diabetes mellitus.
    Demirtunc R; Duman D; Basar M; Bilgi M; Teomete M; Garip T
    J Diabetes Complications; 2009; 23(2):89-94. PubMed ID: 18358749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet aggregation, platelet cAMP levels and thromboxane B2 synthesis in patients with diabetes mellitus.
    Chen SY; Yu BJ; Liang YQ; Lin WD
    Chin Med J (Engl); 1990 Apr; 103(4):312-8. PubMed ID: 2167823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive impairment of erythrocyte deformability as indicator of microangiopathy in type 2 diabetes mellitus.
    Shin S; Ku YH; Ho JX; Kim YK; Suh JS; Singh M
    Clin Hemorheol Microcirc; 2007; 36(3):253-61. PubMed ID: 17361027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. D-chiro-inositol metabolism in diabetes mellitus.
    Ostlund RE; McGill JB; Herskowitz I; Kipnis DM; Santiago JV; Sherman WR
    Proc Natl Acad Sci U S A; 1993 Nov; 90(21):9988-92. PubMed ID: 8234346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Plasma, erythrocyte and platelet magnesium in essential hyperTension, diabetes mellitus without and with macrovascular complications and atherosclerotic vascular disease].
    Grifò G; Lo Presti R; Montana M; Canino B; Caimi G
    Recenti Prog Med; 1995 Nov; 86(11):431-6. PubMed ID: 8539474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of correlation of glycosylated haemoglobin level with the duration of diabetes or diabetic angiopathy.
    Blickle JF; North ML; Brogard JM; Reville P
    Ann Med Interne (Paris); 1986; 137(3):264-6. PubMed ID: 3767198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased inositol phosphate accumulation in platelets from patients with NIDDM.
    Ishii H; Umeda F; Hashimoto T; Nawata H
    Diabetes Res Clin Pract; 1991 Oct; 14(1):21-7. PubMed ID: 1660805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship of oxidative stress to thrombotic tendency in type 1 diabetic patients with retinopathy.
    Jennings PE; McLaren M; Scott NA; Saniabadi AR; Belch JJ
    Diabet Med; 1991 Nov; 8(9):860-5. PubMed ID: 1837513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible relevance of lipid peroxidation and thromboxane production to the initiation and/or evolution of microangiopathy in non-hyperlipidemic type 2 diabetes mellitus.
    Katoh K
    Diabetes Res Clin Pract; 1992 Nov; 18(2):89-98. PubMed ID: 1478157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Release of platelet plasminogen activator inhibitor 1 in whole blood is increased in patients with type II diabetes.
    Jokl R; Klein RL; Lopes-Virella MF; Colwell JA
    Diabetes Care; 1995 Aug; 18(8):1150-5. PubMed ID: 7587850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of myo-inositol treatment on basement membrane thickening in the BB/W-rat retina.
    Chakrabarti S; Sima AA
    Diabetes Res Clin Pract; 1992 Apr; 16(1):13-7. PubMed ID: 1576927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood viscosity and erythrocyte filterability: their evaluation in diabetes mellitus.
    Caimi G
    Horm Metab Res; 1983 Oct; 15(10):467-70. PubMed ID: 6642407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum and erythrocyte magnesium levels in type I and type II diabetics.
    Vanroelen WF; Van Gaal LF; Van Rooy PE; De Leeuw IH
    Acta Diabetol Lat; 1985; 22(3):185-90. PubMed ID: 3907234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.